Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Epigenomes|December 30, 2021
Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma-A Literature UpdateStine Dam Henriksen, Ole Thorlacius-Ussing
Ugeskrift for Laeger|October 9, 2009
[Foetal reduction--a retrospective survey]Mette Heinel Frederiksen, Stine Dam Henriksen, Astrid Julie Bønnelykke, et al.
Pancreas|September 11, 2015
DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature ReviewStine Dam Henriksen, Poul Henning Madsen, Henrik Krarup, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 8, 2023
Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort studyMorten Hasselstrøm Jensen, Simon Lebech Cichosz, Ole Hejlesen, et al.
Computer Methods and Programs in Biomedicine|December 9, 2023
Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parametersSimon Lebech Cichosz, Morten Hasselstrøm Jensen, Ole Hejlesen, et al.
International Journal of Cancer|September 1, 2017
Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma stagingStine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, et al.
Oncotarget|December 8, 2017
Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinomaStine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, et al.
Scandinavian Journal of Gastroenterology|September 3, 2025
A novel prediction model of mortality in chronic pancreatitis using clinical characteristics and gene promoter hypermethylation statusBenjamin Stubbe, Inge Søkilde Pedersen, Poul Henning Madsen, et al.
Scandinavian Journal of Gastroenterology|March 26, 2019
Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibilityRasmus Virenfeldt Flak, Mogens Tornby Stender, Thomas Mandøe Jensen, et al.
Clinical Epigenetics|November 29, 2016
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinomaStine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, et al.
Pageof 2